Search results

Found 970 pages
AUTHOR: Lucy Parsons

Results per page

10 20 50 100

Sort by

Relevance Date

7 Jan 2021:

EU approves Moderna’s COVID-19 vaccine

Vaccine is also currently being reviewed in the UK - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

https://www.pharmatimes.com/news/eu_approves_modernas_covid-19_vaccine_1360881

31 Mar 2021:

NHS extends ‘COVID-friendly’ at-home cancer care

Funding for effective, 'less risky' treatments extended until summer 2021 - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

https://www.pharmatimes.com/news/nhs_extends_covid-friendly_at-home_cancer_care_1366141

11 Feb 2021:

WHO panel recommends AZ/Oxford’s COVID-19 vaccine

WHO's SAGE panel backs wide use of jab in adults, including in people aged over 65 - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

https://www.pharmatimes.com/news/who_panel_recommends_azoxfords_covid-19_vaccine_1363139

17 Feb 2021:

Evgen Pharma recruits over 100 patients into COVID-19 trial

Study is investigating company's lead asset SFX-01 - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

https://www.pharmatimes.com/news/evgen_recruits_over_100_patients_into_covid-19_trial_1363515

13 Sep 2021:

UK terminates Valneva COVID-19 vaccine supply agreement

Gov has alleged that the company breached its obligations under the agreement - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

https://www.pharmatimes.com/news/uk_terminates_valneva_covid-19_vaccine_supply_agreement_1377317

12 Feb 2021:

NHS to roll-out tocilizumab treatment for COVID-19

In the RECOVERY trial, tocilizumab treatment significantly reduced deaths caused by COVID-19 - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

https://www.pharmatimes.com/news/nhs_to_roll-out_tocilizumab_treatment_for_covid-19_1363221

18 Feb 2021:

UK government pledges £18.5m for long COVID research

Funding will be given to four long COVID research studies - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

https://www.pharmatimes.com/news/uk_government_pledges_18.5m_for_long_covid_research_1363628

15 Feb 2021:

CureVac’s COVID-19 vaccine begins rolling review with EMA

CureVac’s CVnCoV is currently being investigated in a randomised, placebo-controlled Phase IIb/III clinical trial - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

https://www.pharmatimes.com/news/curevacs_covid-19_vaccine_begins_rolling_review_with_ema_1363316

13 Jul 2021:

New hope for long COVID blood tests after antibody discovery

Researchers discover presence of 'autoantibodies' in people with persistent COVID-19 symptoms - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

https://www.pharmatimes.com/news/new_hope_for_long_covid_blood_tests_after_antibody_discovery_1373054

12 Mar 2021:

New real-world evidence for Pfizer/BioNTech COVID-19 vaccine

Evidence demonstrates lower incidence rates of COVID-19 in fully vaccinated individuals - News - PharmaTimes

by Lucy Parsons|Lucy Parsons

https://www.pharmatimes.com/news/new_real-world_evidence_for_pfizerbiontech_covid-19_vaccine_1365128